Literature DB >> 29080850

Assessment of novel tobacco heating product THP1.0. Part 7: Comparative in vitro toxicological evaluation.

David Thorne1, Damien Breheny2, Christopher Proctor2, Marianna Gaca2.   

Abstract

In vitro studies have been widely used to support the toxicological evaluation of chemicals and complex mixtures including cigarette smoke. In this study, the total particulate matter and whole aerosol from a Kentucky reference 3R4F cigarette and two commercially available tobacco heating products (THPs) were assessed using in vitro mutagenicity, cytotoxicity and tumour-promoting activity assays. The Ames assay assessed mutagenicity using Salmonella typhimurium tester strains TA98, TA100, TA1535, TA1537 and TA102 ± metabolic activation (S9). The mouse lymphoma assay was used with short 3 h and longer 24 h exposures. The Bhas 42 cell transformation assay was incorporated as an in vitro alternative for detecting tumour promoters, and the neutral red uptake cell viability assay provided an acute measure of cytotoxicity. To complement the approach, the Ames assay was also employed with S. typhimurium tester strains TA98, TA100, TA1535, TA97 and TA102 using a scaled down methodology for the assessment of aerosols. All the in vitro techniques employed produced a clear positive response with cigarette smoke and in contrast, a negative response to THPs at doses equivalent to or higher than a cigarette smoke test matrix. The data show little difference between the THPs assessed suggesting parity between products.
Copyright © 2017 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Ames; Bhas transformation assay; In vitro; Mouse lymphoma; Neutral red uptake; TPM; Tobacco heating products; Whole aerosol

Mesh:

Substances:

Year:  2017        PMID: 29080850     DOI: 10.1016/j.yrtph.2017.08.017

Source DB:  PubMed          Journal:  Regul Toxicol Pharmacol        ISSN: 0273-2300            Impact factor:   3.271


  10 in total

1.  Comparative potency analysis of whole smoke solutions in the bacterial reverse mutation test.

Authors:  Fanxue Meng; Nan Mei; Jian Yan; Xiaoqing Guo; Patricia A Richter; Tao Chen; Mamata De
Journal:  Mutagenesis       Date:  2021-08-27       Impact factor: 3.000

2.  A randomized controlled study in healthy participants to explore the exposure continuum when smokers switch to a tobacco heating product or an E-cigarette relative to cessation.

Authors:  Michael McEwan; Nathan Gale; James K Ebajemito; Oscar M Camacho; George Hardie; Christopher J Proctor; James Murphy
Journal:  Toxicol Rep       Date:  2021-05-08

3.  A novel clinical method to measure skin staining reveals activation of skin damage pathways by cigarette smoke.

Authors:  Annette Dalrymple; Michael McEwan; Marianne Brandt; Stephan Bielfeldt; Emma-Jayne Bean; Alain Moga; Steven Coburn; George Hardie
Journal:  Skin Res Technol       Date:  2021-11-10       Impact factor: 2.240

4.  Changes in Biomarkers of Exposure on Switching From a Conventional Cigarette to Tobacco Heating Products: A Randomized, Controlled Study in Healthy Japanese Subjects.

Authors:  Nathan Gale; Mike McEwan; Alison C Eldridge; Ian M Fearon; Neil Sherwood; Edward Bowen; Simon McDermott; Emma Holmes; Andrew Hedge; Stuart Hossack; Louise Wakenshaw; James Glew; Oscar M Camacho; Graham Errington; John McAughey; James Murphy; Chuan Liu; Christopher J Proctor
Journal:  Nicotine Tob Res       Date:  2019-08-19       Impact factor: 4.244

5.  Potential predictors of adoption of the Tobacco Heating System by U.S. adult smokers: An actual use study.

Authors:  Steve Roulet; Christelle Chrea; Claudia Kanitscheider; Gerd Kallischnigg; Pierpaolo Magnani; Rolf Weitkunat
Journal:  F1000Res       Date:  2019-02-24

Review 6.  Heated Tobacco Products: A Review of Current Knowledge and Initial Assessments.

Authors:  Nadja Mallock; Elke Pieper; Christoph Hutzler; Frank Henkler-Stephani; Andreas Luch
Journal:  Front Public Health       Date:  2019-10-10

7.  Assessing the lung cancer risk reduction potential of candidate modified risk tobacco products.

Authors:  Julia Hoeng; Serge Maeder; Patrick Vanscheeuwijck; Manuel C Peitsch
Journal:  Intern Emerg Med       Date:  2019-02-14       Impact factor: 3.397

8.  An abuse liability assessment of the glo tobacco heating product in comparison to combustible cigarettes and nicotine replacement therapy.

Authors:  George Hardie; Nathan Gale; Michael McEwan; Stefano Milleri Oscar; Luigi Ziviani; Christopher J Proctor; James Murphy
Journal:  Sci Rep       Date:  2022-08-29       Impact factor: 4.996

9.  Challenges in Predicting the Change in the Cumulative Exposure of New Tobacco and Related Products Based on Emissions and Toxicity Dose-Response Data.

Authors:  Yvonne C M Staal; Wieneke Bil; Bas G H Bokkers; Lya G Soeteman-Hernández; W Edryd Stephens; Reinskje Talhout
Journal:  Int J Environ Res Public Health       Date:  2022-08-24       Impact factor: 4.614

10.  Reduced Chronic Toxicity and Carcinogenicity in A/J Mice in Response to Life-Time Exposure to Aerosol From a Heated Tobacco Product Compared With Cigarette Smoke.

Authors:  Ee Tsin Wong; Karsta Luettich; Subash Krishnan; Sin Kei Wong; Wei Ting Lim; Demetrius Yeo; Ansgar Büttner; Patrice Leroy; Grégory Vuillaume; Stéphanie Boué; Julia Hoeng; Patrick Vanscheeuwijck; Manuel C Peitsch
Journal:  Toxicol Sci       Date:  2020-11-01       Impact factor: 4.849

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.